BUSINESS● LOWJun 25 · Jun 25, 2026, 9:48 AM
ARS Pharmaceuticals plunges 23% as neffy fails to secure insurance coverage
Seeking Alpha Tech
ARS Pharmaceuticals experienced a 23% stock drop due to its product, neffy, failing to secure insurance coverage. This development has a notable impact on the company's market performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS17m agoMoody's holds steady on France's credit rating as country grapples with turmoil and higher yieldsCNBCBUSINESS24m agoWSFS outlines 45%-50% deposit beta in current hiking cycle while targeting double-digit Walton Trust growthSeeking Alpha Tech